ClinicalTrials.govpublic full text
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
heart failure with preserved ejection fraction, cardiovascular diseases, heart failure, nt-probnp, 6 mwt, kccq, sf-36, nyha class, lcz696, enalapril, valsartan, angiotensin-converting enzyme inhibitors (acei)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 903668
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.